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Background: Toxoplasma gondii infection can lead to severe disease outcomes in immune-compromised people.
This study sought to determine the seroprevalence of anti-T. gondii antibodies among pregnant women,
hospitalized children (<5 years old) and HIV-seropositive persons in Accra.
Methods: A cross-sectional study was conducted in two hospitals in Accra, and a total of 450 voluntary participants
were recruited for the study consisting of 125 pregnant women, 200 children and 125 HIV-seropositive persons.
Serum was obtained from venous blood safely drawn from each participant and tested for specific anti-Toxoplasma
antibodies IgG and IgM by ELISA. A serological criterion for seropositivity was a positive test result for any of the
two anti-Toxoplasma antibodies or a combination of both. Questionnaire interviews were conducted to obtain
personal information and Toxoplasma infection risk-related data.
Results: Those who tested seropositive for anti-T. gondii antibodies were 51.2 % (64/125) pregnant women, 58.0 %
(116/200) children and 57.6 % (72/125) HIV patients. The major risk factors associated with anti-T. gondii seropositivity
were identified as age (in children), handling raw meat and gravida status (in pregnant women). The results of
this study confirmed that the seroprevalence of T. gondii infection is high among pregnant women, hospitalized
children <5 years old and HIV patients.
Conclusions: A further study to investigate pre-pregnancy infections with T. gondii among women of childbearing
age, seroconversion rate in pregnant women, rate of mother-to-child transmission and reactivated infections among
HIV-seropositive persons is recommended.
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Toxoplasmosis is one of the world’s most common para-
sitic infections caused by Toxoplasma gondii, a ubiquitous
intracellular protozoan parasite of warm-blooded animals
[1–3]. The parasite is known to infect most genera of
warm-blooded animals, including humans, but the defini-
tive host is the felids (cat). Toxoplasmosis is a self-limiting
disease with the parasite encysting after few weeks of in-
fection, but reactivation of infection may occur even in* Correspondence: iayi@noguchi.ug.edu.gh
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pression of one’s immune system leading to significant
morbidity and mortality [4, 5].
Seroepidemiological surveys have revealed varying
degree of prevalence in terms of different geographical
settings and the risk factors for acquiring the disease
[6]. There have also been reports of varying prevalence
in terms of age distribution, climate and socio-economic
status [7–9]. Persons at risk of acquiring toxoplasmosis as
an opportunistic disease usually are immune-compromised
or immune-suppressed persons [10] due to the ability of
the parasite to be reactivated from encysted bradyzoites to
circulating tachyzoites [11].le is distributed under the terms of the Creative Commons Attribution 4.0
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there are instituted national programmes that aim to screen
pregnant women for toxoplasmosis, and such interventions
have helped reduce the rate of congenital transmission and
the rate of seroconversion due to early diagnosis [12, 13].
During pregnancy, there is the occurrence of a high
cascade of complex physiological conditions that en-
ables the mother to fully adapt to the environment.
Immune-suppression is noted to be a physiological change
that the body of the mother induces for the prevention of
foetal rejection as the foetus is considered as an allograft.
This, therefore, makes the pregnant woman susceptible to
many opportunistic infections [14]. However, in Ghana,
like most sub-Saharan African countries, there is no
national programme for screening pregnant women for
toxoplasmosis.
HIV infections on the other hand cause progressive
depletion of the CD4+ T cells, which leads to life-
threatening opportunistic infections (OIs) or malignancies
during the natural course of the disease [15]. Thus, in
chronic toxoplasmosis infected patients, there can be
reactivation of a latent infection which can cause life-
threatening encephalitis [16].
Primary infection of T. gondii during pregnancy can
result in the vertical transmission of tachyzoites which
can have severe consequences on the foetus such as reti-
nochoroiditis, hydrocephalus and intracranial calcifica-
tion of the children and long-term ocular lesions [17].
In Ghana, however, until recently when attention is
being given to toxoplasmosis [18, 19], there is not much
evidence-based information on T. gondii infections among
high-risk groups in the populace. This therefore makes it
difficult for the formulation and adoption of a national
policy for toxoplasmosis management. We therefore
sought to determine the level of exposure of infection
among HIV-seropositive people, pregnant women and
hospitalized children to T. gondii due to their suppressed
or underdeveloped immune status.
Methods
Study area
The ante-natal unit, Obstetrics and Gynaecology Depart-
ment and the Fevers Unit, Medical Department both at
the Korle-Bu Teaching Hospital (KBTH) served as the
recruiting sites for pregnant women and HIV-seropositive
patients, respectively. KBTH is the leading tertiary referral
hospital in Ghana with over 2000 bed capacity. The
Princess Marie Louise Children’s Hospital (PMLCH), an
exclusively referral children’s hospital in Accra, served as
the site for recruiting children <5 years old.
Study population
The study population consisted of pregnant women
aged >18 years (in any trimester of pregnancy) attendingante-natal clinic, male and female Outpatient Department
attendees of the Fevers Unit, aged above 18 years who
were HIV-seropositive and not yet started treatment with
antiretroviral therapy and all at the KBTH as well as chil-
dren of both sexes aged <5 years admitted at the PMLCH.Sampling and sample size
For calculation of the sample size, we assumed a minimum
of 10 % and a maximum 90 % T. gondii seroprevalence as
expected frequency of the factor under study and a confi-
dence level of 95 %. The result of the calculation was a
minimum of 138 subjects for accurate statistical inference
[20]. A convenience sampling method was used to sample
for the participants, and elements of bias were controlled
by ensuring that the sample was a miniature of the whole
population under study.Sample collection
For participants aged above 18 years, 3–5 ml of blood
was drawn from the cubital vein using a sterile hypoder-
mic syringe, and the blood was transferred into labeled
serum separator tubes. For children <5 years old, 3 ml of
blood was obtained from heel prick and transferred into
labeled serum separator tubes. All blood samples were
transferred in cool boxes containing ice-packs to the la-
boratories of the Department of Parasitology, Noguchi
Memorial Institute for Medical Research (NMIMR), for
further analysis. Serum was obtained from each blood
sample by centrifugation at 14,000 rpm for 10 min and
stored at −20 °C until assayed for anti-T. gondii antibodies.Socio-demographic and toxoplasmosis risk-related data
collection
Close-ended questionnaires were administered to collect
demographic as well as toxoplasmosis-related risk fac-
tors data. Questionnaires were administered in an inter-
view format in participants’ mother language for easy
understanding.
Questions sought personal information on participants
including their knowledge about the disease and expos-
ure to possible Toxoplasma infection transmission risk
factors. The possible infection transmission risk factors
considered in the questionnaire included handling and
eating of meat from high transmission risk animals (pigs,
sheep and goats) and contact with cat. With reference to
meat, they were asked how often they handled and/or
ate the meat and what form they preferred their meat
(thoroughly and/or partially cooked). The pregnant women
and the parents of the children were also asked if they
owned cats or pets or had cats in their house or immediate
surroundings.
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immunosorbent assay
Each sample was tested for the presence of anti- T. gondii
antibodies, IgG and IgM, using commercial ELISA kits
(CTK Biotech. Inc., San Diego, CA, USA) and following
manufacturer instructions. Briefly, 100 μl (for IgG) and
50 μl (for IgM) of sample diluent was added to the test
wells of the 96-well microtitre plates (pre-coated with T.
gondii antigen), and 10 μl of each test serum was added to
each test well. The wells were then incubated at 37 °C for
30 min after which they were completely and thoroughly
washed with wash buffer. One hundred microlitres of
HRP-anti-human IgG conjugates or HRP-anti-human IgM
conjugates (depending on the test) were added to each of
the wells except the blank wells and incubated at 37 °C for
20 min after which wells were thoroughly washed. Fifty
microlitres each of TMB (3, 3′, 5, 5′-tetramethylbenzi-
dine) substrates A and B was added to the test wells. The
96-well microplate was then incubated in the dark for
10 min at 37 °C, and the reaction was stopped by adding
50 μl of stop buffer. Optical densities (OD) were then
measured using a 450-nm ELISA plate reader, Multiskan™
Microplate Absorbance Plate Reader (Thermo Scientific,
USA). The cut-off value was given as N + 0.15, where N
was the mean OD of the negative control. The OD of each
specimen was calculated as the ratio of the specimen OD
and the cut-off value. The mean OD value of the T gondii
IgG and IgM positive controls was expected to be ≥1.0
and that of negative controls was expected to be ≤0.10.
Samples with an OD ratio <1.00 was considered to be
negative with samples having an OD ratio ≥1.00 consid-
ered positive.
Statistical analysis
Data analysis was performed using SPSS version 16.0.
Difference in non-scalable variables such as age and sex of
the study populations were assessed by Mann-Whitney
U rank sum with p values <0.05 considered significant
(CI 95 %). Chi-square (χ2) test was used to determine
associations between categorical variables. p values <0.05
was considered statistically significant. Univariate analysis
was used to predict the association between T. gondii




Age (years) Range 16–44
Mean 28.25 ± 3.65
Gender Male (%) –
Female (%) 125 (100)Results
Participant characteristics
A total of four hundred and fifty (450) patients participated
in this study. They comprised of 125 pregnant women aged
16 to 44 years (mean 28.25 ± 3.65) across trimesters;
200 children aged 0 to 5 years (mean 2.62 ± 1.31); and
125 HIV-seropositive persons aged 15 to 68 years (mean
43.24 ± 4.97) (Table 1). There was a significant difference
between the ages of the study groups.Prevalence of anti-T. gondii IgG and IgM antibodies
Seroprevalence of anti -T. gondii IgG among pregnant
women, children and HIV-seropositive persons were
51.2 % (64/125), 58.0 % (116/200) and 57.6 % (72/125),
respectively. A seroprevalence of 0.5 % (1/200) anti-T.
gondii IgM was recorded among the children. However,
there was no record of anti-T. gondii IgM in pregnant
women and HIV-seropositive persons (Table 2).Test of association between anti-T. gondii seropositivity
and socio-demographic variables in pregnant women and
HIV-seropositive persons
Demographic and clinical factors were related to sero-
positivity of anti-T. gondii antibodies. Results indicated
no significant association between gender and the sero-
positivity for anti-T. gondii IgG. Furthermore, factors
such as age (all study participants), stage of pregnancy
and CD4+ T cell count/mm3 were found not to have any
statistical significance among pregnant women and HIV-
seropositive persons, respectively. However, there was a
significant association between the gravida status of the
pregnant women and anti-T. gondii seropositivity (Table 3).
Exposure to infection risk factors such as owning a cat
and contact with soil (due to their daily activities) as well
as the handling and eating of raw or undercooked meat
did not show any statistically significant associations with
anti-T. gondii seropositivity in both pregnant women and
HIV-seropositive persons. However, there was a significant
association between handling of meat (beef, pork, mutton
and chevron; among pregnant women only) and anti-T.
gondii IgG positivity (p = 0.02; CI 95 %) (Table 4).nts
en Children <5 years old HIV-seropositive
200 125
0–5 15–68
2.62 ± 1.31 43.24 ± 4.97
109 (54.5) 54 (43.2)
91 (45.5) 71 (56.8)
Table 2 Seroprevalence of anti-Toxoplasma gondii antibodies
among study participants
T. gondii seropositivity n (%)
Study participants Number tested IgG only Both IgG and IgM
Pregnant women 125 64 (51.2) 0
Children 200 116 (58.0) 1 (0.5)
HIV-seropositive 125 72 (57.6) 0
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Children in all age groups tested for anti-T. gondii anti-
bodies showed a significant association with age and
seropositivity with p values <0.05 (CI 95 %). Results indi-
cated an apparent linear increase in seropositives in the
different ages of the children as shown in the Table 3.
The lowest seroprevalence of 22.2 % (6/27) was recorded
in the 0- to 0.5-year-old group and is likely to be circu-
lating maternal antibodies and steadily increased in the
other age groups with the highest seroprevalence of
71.6 % (53/74) being recorded in children aged between
3 and 5 years.
Discussion
The current study was conducted to determine the sero-
prevalence of anti-T. gondii antibodies among immune-
suppressed groups of people represented by pregnant
women, children and HIV-seropositive persons in Accra.
All three groups recorded serum anti-T. gondii antibodies
positivity of more than 50 %. A previous study among
pregnant women (mean age of 28.1 years) in Accra,
Ghana, yielded a seroprevalence of 92.5 % [18]. However,
another hospital-based study in patients of mean age
30.2 years visiting the Korle-Bu Teaching Hospital in
Accra reported a lower prevalence rate of 49.7 % [19]. A
recent population-based study in coastal Ghana also re-
ported a seroprevalence of 85 % [8]. These disparities in
toxoplasmosis seroprevalence estimates could be due to
several factors such as study and geographical and climatic
factors which are known to influence seroepidemiological
studies [21]. Similar studies in other African countries
have revealed varying prevalence such as 58.4 % in Tunisia
[22], 53.6 % in Benin [23] and 57.9 % in Egypt [24].
This study showed no significant association between
anti-T. gondii antibody detection and presence of domestic
cats, and this is in contrast with the results of studies re-
ported in Nigeria [25], India [26] and Tanzania [27]. As
IgM is considered as an indicator for recent/acute infection,
our data suggests that there were no recent active infections
in the pregnant women nor HIV-seropositive persons. The
non-detection of IgM suggests that there were no recent in-
fections; however, the presence of IgG could be due to reac-
tivated or past infections [28].
It is crucial in pre- natal screening to ascertain whether
T. gondii infection was acquired before or after conception[12, 14]. Primary congenital toxoplasmosis can lead to
parasite transmission to the foetus via the placenta where
the risk of transmission increases during gestation [29]. In
seroepidemiological studies for T. gondii infection, the de-
tection of anti-IgM antibodies in combination with anti-
IgG antibodies is always an indication of acute infections
[30]. The reason is that IgM antibodies are not usually in
acquired immunity and very rare in chronic infections.
Furthermore, the presence of IgG together with IgM in
circulation indicates recent acquired infection because;
IgM antibodies wane down rapidly following recently ac-
quired infections [18].
The current study recorded an overall seroprevalence
of anti-T. gondii infection in children to be 58.5 % for
anti-T. gondii IgM and/or anti-T. gondii IgG. One (1)
male infant aged 4 years tested positive for anti-T. gondii
IgM. This is an indication of primary infection. Consid-
ering his age infection, he must have acquired the infec-
tion through exposure to any of the potential related
risk factors. The seroprevalence recorded in this study
was higher than the values reported for children of simi-
lar ages in a Nigerian study which reported 23.8 % sero-
prevalence [31]. The difference in seropositivity rates
could probably be due to the diagnostic techniques used
which has variable sensitivities and specificities and also
due to the local potential relative risk factors associated
with the geographical areas.
This study found a statistically significant association
between seroprevalence and age in children. Findings
from the study showed a linear increase from the <6 months
old children which recorded a 22.2 % seroprevalence to the
3- to 5-year-old children which recorded a seroprevalence
of 71.6 %. This observation was in agreement with studies
done elsewhere, in which the seroprevalence of T. gondii in-
fection was found to increase with age [10, 32]. Previous
studies had observed that there was a rapid increase in
anti-T. gondii IgG seroprevalence from ages 6 months to
5 years and then plateaued through age 10 years [33]. One
hypothesis is that this trend simply reflects the increasing
number of “exposure years” as children aged [33]. As chil-
dren tend to grow, they get in contact with soil which is
known to be a high-risk factor in terms of exposure to T.
gondii oocysts. Also in children <6-month-old age group,
the IgG antibodies found are likely to be circulating mater-
nal antibodies which has been passively passed on to the
children or may be due to congenital infection. Establish-
ment of congenital transmission however depends on the
detection of parasite DNA in the foeto-placental region of
the placenta [1, 28, 34], and thus, anti-T. gondii antibodies
will not be a conclusive diagnostic test.
Although pre-pregnancy T. gondii infection status of
the pregnant women is unknown, it could be deduced
from the antibodies detected and age of pregnancy that
there is a possibility of having acquired the infection
Table 3 Demographics associated with Toxoplasma seropositivity in participants by univariate analysis
Study participants Number examined (N) Anti-Toxoplasma gondii seropositivity (n/N; %) χ2 value p value (CI 95 %)
Pregnant women 125 64 (51.2)
Age groups
16–20 4 4 (100) 3.94 <0.05*
21–30 57 30 (52.6) 0.08 0.76
31–40 58 27 (46.6) 0.94 0.33
41–44 6 3 (50.0) 0.04 0.95
Stage of pregnancy
1st trimester 7 4 (57.1) 0.11 0.74
2nd trimester 38 22 (57.8) 0.98 0.32
3rd trimester 80 38 (47.5) 1.21 0.26
Gravida status of women
Primigravids 49 17 (34.7) 8.79 0.003*
Multigravids 76 47 (61.8)
HIV-seropositive persons 125 72 (57.6)
Age groups
15–24 4 1 (25.0) 1.79 0.17
25–34 27 16 (59.3) 0.04 0.84
35–44 51 26 (50.9) 1.54 0.21
45–54 30 20 (66.7) 1.32 0.25
55–64 12 8 (66.7) 0.44 0.50
65–68 1 1 (100) 0.74 0.389
Gender
Male 54 32 (59.2) 0.10 0.74
Female 71 40 (56.3)
CD4+ T cell count cell/mm3
<200 9 6 (66.7) 0.32 0.56
200≥ CD4+ ≤ 500 64 38 (59.4) 0.16 0.68
>500 52 28 (53.8) 0.52 0.47
Children <5 years of age 200 117 (58.5)
Age groups
0–6 months 27 6 (22.2) 26.46 <0.001*
6–12 months 30 9 (30.0) 11.80 <0.001*
1–3 years 69 48 (69.6) 5.31 0.02*
3 years > X < 5 years 74 53 (71.6) 7.32 <0.001*
Gender
Male 109 68 (62.4) 1.18 0.27
Female 91 49 (53.8)
p value was calculated by Pearson’s chi-square (χ2) with confidence interval (CI) of 95 % and 1 degree of freedom (df). p values less than 0.05 were considered
statistically significant and are indicated in bold fonts (*)
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have shown that T. gondii infections acquired by the
mother during the first trimester of gestation has a
10–15 % risk of being transmitted congenitally to the
foetus with severe consequences [14] whereas mothers
contracting the infection during the second or thirdtrimesters has an increasing (up to 68 %) risk of infecting
their unborn babies, with less severe consequences [14].
This is therefore an indication that almost all the seroposi-
tive pregnant women identified in this study stand a risk
of transmitting the infection to their foetuses. However,
this study cannot conclusively ascertain whether there
Table 4 Association of infection risk variables with Toxoplasma gondii seropositivity in pregnant women and HIV patients by
univariate analysis




χ2 value p value (CI 95 %)
Pregnant women (N0 = 125) Own a cat
Yes 56 (44.8) 28 (50.0) 0.058 0.808
No 69 (55.2) 36 (52.1)
Contact with soil
Yes 14 (11.2) 7 (50.0) 0.009 0.92
No 111 (88.8) 57 (51.4)
Handle raw meat
Yes 114 (91.2) 62 (54.4) 5.26 0.02*
No 11 (8.8) 2 (18.2)
Eat raw meat
Yes 28 (22.4) 14 (50.0) 0.02 0.88
No 97 (77.6) 50 (51.5)
HIV-seropositive patients (N0 = 125) Own a cat
Yes 42 (33.6) 26 (62.0) 0.47 0.48
No 83 (64.4) 46 (55.4)
Contact with soil
Yes 64 (51.2) 35 (54.7) 0.45 0.49
No 61 (48.8) 37 (60.7)
Handle raw meat
Yes 75 (60.0) 40 (53.3) 1.39 0.23
No 50 (40.0) 32 (64.0)
Eat raw meat
Yes 111 (88.8) 66 (59.5) 1.40 0.23
No 14 (11.2) 6 (42.9)
p value was calculated by Pearson’s chi-square (χ2) with confidence interval (CI) of 95 % and 1 degree of freedom (df). p values less than 0.05 were considered
statistically significant and are indicated in bold fonts (*)
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and as such the rate of congenital transmission cannot be
determined.
Toxoplasmosis is the most common opportunistic in-
fection in HIV-seropositive immune-compromised hosts,
where it occurs predominantly as a reactivation of en-
dogenous infection [35].
Until the last couple of decades, most human T. gondii
infections were thought to be the result of contact with
soil contaminated with the oocysts, since T. gondii oocysts
can survive for years in soil [4]. Recently, many infections
are thought to result from other related risk factors in-
cluding cat ownership, eating raw or undercooked pork,
meat and meat products, consumption of raw and un-
washed vegetables [8, 9] and drinking from contaminated
reservoir [36].
In the current study, some variables were identified as
possible infection risk factors and were independently
linked to a higher risk of T. gondii infection. The handlingof raw meat (which includes beef and pork) among preg-
nant women had statistically significant association with
anti-T. gondii seropositivity as a higher proportion of
the pregnant women that reported handling raw meat
(62, 54.4 %; N = 114) had anti-T. gondii antibodies than
the non-raw meat handlers (2, 18.2 %; N = 11). Handling
of raw meat was however not a significant risk factor in
HIV-seropositive patients as the proportion of non-raw
meat handlers with anti-T. gondii seropositivity (32,
64.0 %; N = 50) was higher than the raw meat handlers
(40, 53.3 %; N = 75) although the number of the latter was
higher than the former (Table 4). Toxoplasma tissue cysts
contained in meat or meat-derived products have been
shown to serve as important sources of infection for
humans [8] and that the risk of acquiring the infection via
meat sources depends on cultural and eating habits in dif-
ferent human populations. Cat ownership did not show
any significant association with T. gondii seropositivity in
this study. These findings are in contrast to those of
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central role in the epidemiology of T. gondii, constituting
the only known source of environmental contamination
with the infective oocyst stage. However, in support of our
findings, other epidemiological studies have not shown cat
ownership to be a high-risk factor for T. gondii infection
[38] but rather exposure to the faeces from a cat that is
shedding oocysts.
The seemingly high seroprevalence recorded in the
children as compared to the two adult study populations
may be possibly due to a variety of factors. Firstly, it is
possible that the children had been exposed to risk fac-
tors that adult populations in this study had not been
exposed to during their childhood. With the increase in
urbanization and industrialization in many parts of Ghana,
it is possible that there is an increased risk for T. gondii
infection. The increase in urban slums is a potential
high-risk point for disease transmission including T. gondii
because of inaccessibility to clean water, unhygienic prac-
tices and inadequate sanitation. Also, the recruitment at an
exclusively referral children’s hospital may be a confound-
ing factor and that results obtained may not generally be
same for supposedly healthy children in the country.Conclusions
In conclusion, the results of this study confirmed that the
seroprevalence of T. gondii infection is high among preg-
nant women, children <5 years old and HIV-seropositive
persons in Accra. The major risk factors associated with T.
gondii seropositivity in the present study were age and con-
tact with raw meat (among only pregnant women). A fur-
ther study to investigate pre-pregnancy infections with T.
gondii among women of childbearing age, seroconversion
rate in pregnant women, rate of mother-to-child transmis-
sion and reactivated infections among HIV-seropositive
persons is recommended. Such evidence will add up to
existing information to improve control and management
of toxoplasmosis in Ghana, especially for women of child-
bearing age in Ghana.
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